top of page


Confirmed Speakers




  • ITOC8 Lifetime Achievement Award
    Uğur Şahin and Özlem Türeci
    BioNTech SE, Mainz, Germany

    "Translating the success of the mRNA vaccine to cancer"


In alphabectical order

  • Niroshana Anandasabapathy, Weill Cornell New York, NY, USA

  • Mads Hald Andersen, National Center for Cancer Immune Therapy, Copenhagen, Denmark 

  • Gregory L. Beatty, University of Pennsylvania, Philadelphia, PA, USA

  • Marcus Bosenberg, Yale School of Medicine, New Haven, CT, USA

  • Philippe Bousso, Department of Immunology, Institut Pasteur and INSERM, Paris, France

  • Tullia C. Bruno, UPMC Hillman Cancer Center, Pittsburgh, PA, USA

  • Dirk Busch, TUM, Munich, Germany

  • Toos Daemen, University Medical Center Groningen, The Netherlands

  • May Daher, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

  • Tanja de Gruijl, Cancer Center Amsterdam, The Netherlands

  • Bernard A. Fox, Providence Portland Medical Center, Portland, OR, USA

  • Saar Gill, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

  • Brent Hanks, Duke University, Durham, NC, USA

  • Maija Hollmen, University of Turku, Turku, Finland

  • David S. Hong, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

  • Samuel Huber, University of Hamburg, Faculty of Medicine, Hamburg, Germany

  • Sebastian Kobold, Ludwig-Maximilians-Universität, Munich, Germany

  • Nicolaus Kröger, University Hospital Hamburg-Eppendorf, Hamburg, Germany

  • X. Shirley Liu, Dana-Farber Cancer Institute and Harvard University,  Boston, MA, USA

  • Jason J. Luke, University of Pittsburgh Medical Center, Pittsburgh PA, USA

  • Fathia Mami-Chouaib, Institut de Cancérologie Gustave Roussy, Villejuif, France

  • Cornelis Melief, ISA Pharmaceuticals, Leiden, The Netherlands

  • Meriem Messaoudene, Centre Hospitalier de l'Université de Montréal, Canada

  • Patrick A. Ott, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA, USA

  • Chong-Xian Pan, Harvard Medical School, Boston, MA, USA

  • Stanley R Riddell, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA

  • Marco Ruella, University of Pennsylvania, Philadelphia, PA, USA

  • Sabina Signoretti, Harvard Medical School, Department of Pathology, Boston, MA, USA

  • Philipp Staber, Medical University of Vienna, Austria

  • Febe van Maldegem, The Francis Crick Institute, London, United Kingdom

  • Michael von Bergwelt, LMU, CCC, DKTK, Munich, Germany

  • Dietmar Zehn, Animal Physiology and Immunology, Technical University of Munich, Germany

The website is continuously updated as feedback from invited speakers is received.


ITOC8 has been granted 11 European CME credits

Session Topics

  • ​Emerging Concepts / New Agents

  • Tumor microenvironment and microbiome in Immunotherapy

  • Vaccine Therapy

  • Pro & Contra Session

  • Precision Medicine Meets Immunotherapy (Immuno-Monitoring)

  • “Lost in Translation”?

  • Lifetime Achievement Award

  • Cell Therapy in Solid Tumors

  • Cell Therapy in Haematologic Diseases

  • Combination Therapy

  • Young Researchers Session

  • Best Poster Awards

bottom of page